JPMorgan Chase holds annual medical health summit

Sina Financial News on January 16, JPMorgan's annual health summit was held in San Francisco from January 13 to 16 The summit is the largest and most informative healthcare investment seminar in the industry, bringing together industry leaders, fast-growing emerging enterprises, innovative technology creators and investment professionals The 2020 summit attracted more than 9000 participants and discussed topics such as health care industry outlook, latest technology, investment direction, digital medicine, drug price, population aging, etc More than 450 unlisted and listed companies gave on-site presentations to show the latest trend and future development direction of the medical and health industry This year, the number of participating enterprises from China continued to grow, with 62 Chinese enterprises participating in the conference (last year, 38), one third of which gave on-site promotion speeches The summit also set up a sub Forum on "China's pharmaceutical innovation and research and development", chaired by Zhang Ling, head of medical health and technology in China, JPMorgan global investment bank, with guests including song Ruilin, President of China pharmaceutical innovation promotion association, Yu Dechao, chairman and general referee of Xinda biopharmaceutical, and Kingsley biotechnology Founder and CEO Zhang Fangliang and senior vice president of Hong Kong Stock Exchange Chen Wendong In addition, during the summit, the "China CEO dinner" hosted by JPMorgan Chase entered its second year this year Industry heavyweight guests from more than 50 Chinese biotechnology and biomedical companies attended the dinner and reception, and jointly discussed the development trend of China's medical and health industry, as well as the latest developments of the global capital market "The rapid growth in this key area of healthcare has created a unique opportunity for JPMorgan and our customers to better participate in China's' growth story 'as the Chinese economy shifts from heavy industry and manufacturing driven to innovation, technology and consumption driven," said Huang Guobin, China head of JPMorgan global investment bank "Based on China's population, with the aging population, rising income, the development of medical and health services and the progress of science and technology, the growth prospect of China's medical and health industry is expected to be, or will continue to attract the attention of investors." JPMorgan is a leading financial institution in the global healthcare industry China's healthcare industry is also of strategic importance to JPMorgan Chase, which has continued to improve its investment banking services in the healthcare sector in recent years In 2018, it took the lead to participate in the listing of Ping an good doctor in Hong Kong of US $1.1 billion and Cinda bio in Hong Kong of US $485 million In 2019, JPMorgan participated in transactions including smiledirect Club listing in the United States of America of US $1.35 billion, deciphera's additional issuance of US $400 million, tripod pharmaceutical's additional issuance of US $230 million and vivia bio's listing in Hong Kong of US $198 million In December 2019, JPMorgan announced that it has obtained the license for securities and futures business issued by China Securities Regulatory Commission, which indicates that JPMorgan securities (China) Co., Ltd., a securities company controlled by JPMorgan, can formally carry out business abroad Some of the Chinese medical and health enterprises participating in the conference include: Legend Biotechnology Corporation 111 group (111, Inc.) of Lee's Pharmaceutical Holdings Ltd and Canbridge of Luye Pharmaceutical Group Ltd of Hutchison China Meditech Limited We doctor group limited, ark Biosciences Inc, Sino biopharmaceutical Ltd, Ping an good doctor, Arrail group, innovent biology Inc, 3sbio Inc Genscript Corp's JPMorgan healthcare summit began in 1983, when it was hosted by Hambrecht & Quist (H & Q) The company was acquired by Chase Bank in 2000 and J.P Morgan a year later At the beginning of the event, only 20 participating companies and about 200 participants focused on the biotechnology industry Today, JPMorgan health summit is still held in San Francisco's Westin St Francis Hotel, but it has developed into a grand event attracting thousands of investors around the world Hundreds of companies giving on-site presentations cover all kinds of industries, from start-ups to large companies with a market value of more than $300 billion, including pharmaceutical companies, medical and health service providers, for-profit or non-profit organizations, medical equipment companies and other sectors of the medical and health industry About JPMorgan group JPMorgan group (New York Stock Exchange: JPM) is a leading financial services company in the world, with total assets of US $2.7 trillion and global business The company enjoys a leading position in investment banking, consumer and small business financial services, commercial banking services, financial transaction processing, asset management and other fields As a component of the Dow Jones industrial average, JPMorgan group serves millions of private customers in the United States and many well-known enterprises, institutions and government customers around the world through its JPMorgan and JPMorgan brands For more information about JPMorgan, please visit: http://www.jpmorganchase.com.